Novartis Unit Hits Roche With HIV Patent Suit
Novartis Vaccines and Diagnostics Inc. has launched a legal battle alleging Hoffmann-La Roche Inc.'s HIV fusion inhibitor, Fuzeon, infringes one of the Swiss drug maker's patents....To view the full article, register now.
Already a subscriber? Click here to view full article